Omri Amirav-Drory, PhD, is the founder and CEO of Genome Compiler, a synthetic biology venture. Prior to starting his company, Omri was a Fulbright postdoctoral research fellow at Stanford University School of Medicine and HHMI, performing neuroscience research using structural and synthetic biology methods. Omri received his PhD in biochemistry from Tel-Aviv University for biochemical and structural studies of membrane protein complexes involved in bio-energetics.
Antony Evans has an MBA...
Have a question about this project?Ask a question